Selecta, In Consultation With The Company's Board Of Directors, Plans To Halt Further Investments In Its Pipeline Programs Outside Of SEL-212 And Stop Or Discontinue Non-essential Activities
Portfolio Pulse from Benzinga Newsdesk
Selecta Biosciences has announced plans to halt further investments in its pipeline programs, excluding SEL-212. The company will also stop or discontinue non-essential activities, following consultation with its board of directors.
August 17, 2023 | 11:10 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Selecta Biosciences' decision to halt investments in pipeline programs, except for SEL-212, and discontinue non-essential activities may impact the company's future growth prospects.
The decision to halt investments in pipeline programs, except for SEL-212, indicates a shift in the company's strategy. This could potentially impact the company's future growth prospects and investor sentiment, leading to a potential decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100